All Stewart A. Anderson (Associate Chair for Research in the department of child and adolescent psychiatry and behavioural sciences at CHOP) articles
-
NewsCholesterol drug restores brain barrier function in 22q11.2 syndrome models
Researchers have found that mitochondrial dysfunction in the blood-brain barrier may drive neuropsychiatric disease in 22q11.2 deletion syndrome – and that a cholesterol drug could restore barrier function and ease symptoms.